N-(5-取代-1,3,4-噻二唑-2-基)-1,4-二取代-3-苯基-1H-吡唑-5-甲酰胺化合物的合成与生物活性

以3-苯基-1H-5-吡唑甲酸乙酯为原料,合成了3种吡唑甲酰氯;以不同取代羧酸和氨基硫脲为原料,三氯氧磷为脱水剂,合成6种1,3,4-噻二唑衍生物.设计将吡唑结构单元及1,3,4-噻二唑结构单元结合在一起,合成18个未见文献报道的目标化合物.所合成的目标化合物经元素分析,IR,NMR进行了结构表征.采用小麦芽鞘法测试其生长素活性,所合成的目标化合物的生长素活性均不高,有的对小麦芽鞘具有抑制作用;而对绿豆发芽率测试结果显示,所有目标产物对绿豆发芽过程均具有促进作用.     

3-取代-6-吡唑基-1,2,4-三唑并[3,4-b]-1,3,4-噻二唑类衍生物的合成及生物活性

将5-取代吡唑-3-甲酸乙酯1位甲基化,经水解反应得到3种中间体1-甲基-5-取代1H-吡唑-3-甲酸（2a~2c）;以不同取代的羧酸为原料经一系列反应合成6种中间体3-取代4-氨基-5-巯基-1,2,4-均三唑（3a~3f）;将中间体（2a~2c）和（3a~3f）在三氯氧磷条件下反应,合成出18种1,2,4-三唑并[3,4-b]-1,3,4-噻二唑类化合物(4a~4r),均未见文献报道。 通过IR、1H NMR、13C NMR和元素分析表征了化合物结构。 初步的生物活性测试结果显示,所合成的化合物均表现出不同程度的生长素活性和抑菌活性。 并选取抑菌活性较好的两个化合物进行抗菌药物最低抑菌浓度(MIC)的测定。     

3-取代-1-(5-芳基-1,3,4-噻二唑-2-基)-1H-吡唑-4-甲醛的合成、晶体结构及抑菌活性

以2-氨基-5-取代-1,3,4-噻二唑为起始原料,设计合成16个含1,3,4-噻二唑取代基的中间体4a~4p,进而使其在POCl₃及DMF作用下反应得到16个3-取代-1-(5-芳基-1,3,4-噻二唑-2-基)-1H-吡唑-4-甲醛化合物5a~5p,所合成的32个化合物均为新化合物。 采用溶液结晶法获得化合物5a晶体,通过X射线单晶衍射测得该晶体属于三斜晶系,P-1空间群。 借助 IR、¹H NMR、元素分析等技术手段对合成的所有化合物结构进行了表征。 利用微量稀释法测试了化合物5a~5p的抑菌活性,结果表明,部分化合物对金黄色葡萄球菌具有抑制作用,在相同条件下化合物5h的抑菌活性最好,抑菌率达到65.30%。     

含吡唑取代基的1,2,4-三唑[3,4-b]-1,3,4-噻二唑类衍生物的合成及生物活性

以4-氨基-5-巯基-1,2,4-均三唑的衍生物和5-吡唑甲酸及其衍生物为原料,设计合成21个未见报道的新的3-取代-6-吡唑基-1,2,4-三唑[3,4-b]-1,3,4-噻二唑类化合物.通过IR和1H NMR及元素分析对化合物结构进行表征.小麦芽鞘法对目标化合物生长活性测试结果表明,所合成的化合物均表现出不同程度的生长活性;抑菌活性测试结果表明部分化合物表现出较好的抑菌活性.其中化合物3g和3h的活性最好,与氯霉素相似.对大肠杆菌和金黄色葡萄球菌的抗菌药物最低抑菌浓度(MIC值)3g达到6.25和3.13 mg/L,3h达到12.5和6.25 mg/L.     

2-取代-5-吡唑基-1，3，4-恶二唑类化合物的合成及生物活性

以5-吡唑甲酰肼和取代羧酸为起始物,运用"一锅煮"法合成了一系列2-取代-5-吡唑基-1,3,4-二唑.此外,还合成了1-苯酰基-2-吡唑酰基肼.初步生物活性测定结果表明,部分化合物有较好的杀菌和除草活性.     

2-[5'-CH3(H)-苯并咪唑-2'-亚甲硫基]-5-取代-1,3,4-噁二唑的合成及生长素活性

以邻苯二胺(或4-甲基邻苯二胺)及一氯乙酸为原料,在酸性条件下,合成2-氯甲基苯并咪唑及2-氯甲基-5-甲基苯并咪唑;以取代羧酸为原料经酯化、肼解、再与CS2在氢氧化钾溶液中反应,合成10种2-巯基-5-取代-1,3,4-噁二唑;将2种2-氯甲基-5-取代-苯并咪唑与10种2-巯基-5-取代-1,3,4-噁二唑在氢氧化钠溶液中反应,合成14种2-[5’-CH3(H)-苯并咪唑-2’-亚甲硫基]-5-取代-1,3,4-噁二唑衍生物。借助红外光谱、核磁共振氢谱和元素分析对化合物结构进行表征。初步生长素活性测试结果表明,所合成的化合物对小麦芽鞘和绿豆发芽有着不同程度的生长调节作用。     

2-[5'-CH3(H)-苯并咪唑-2'-亚甲硫基]-5-取代-1,3,4-(口恶)二唑的合成及生长素活性

以邻苯二胺(或4-甲基邻苯二胺)及一氯乙酸为原料,在酸性条件下,合成2-氯甲基苯并咪唑及2-氯甲基-5-甲基苯并咪唑;以取代羧酸为原料经酯化、肼解、再与CS2在氢氧化钾溶液中反应,合成10种2-巯基-5-取代-1,3,4-(口恶)二唑;将2种2-氯甲基-5-取代-苯并咪唑与10种2-巯基-5-取代-1,3,4-(口恶)二唑在氢氧化钠溶液中反应,合成14种2-[5’-CH3(H)-苯并咪唑-2’-亚甲硫基]-5-取代-1,3,4-(口恶)二唑衍生物.借助红外光谱、核磁共振氢谱和元素分析对化合物结构进行表征.初步生长素活性测试结果表明,所合成的化合物对小麦芽鞘和绿豆发芽有着不同程度的生长调节作用.     

微波辐射下合成2-(未)取代苯甲酰胺基-5-(1-苯基-3-甲基-5-氯吡唑- 4-基)-1,3,4-噻二唑衍生物

分别在微波辐射和常规加热条件下, 通过2-氨基-5-(1-苯基-3-甲基-5-氯吡唑-4-基)-1,3,4-噻二唑(1)与(未)取代苯甲酰氯(2a～2j)反应, 合成了一系列未见文献报道的2-(未)取代苯甲酰胺基-5-(1-苯基-3-甲基-5-氯吡唑-4-基)-1,3,4-噻二唑衍生物(3a～3j). 标题化合物的结构经元素分析, IR, 1H NMR确证.     

超声辐射下合成1-[(未)取代苯酰基-3-[5-(1-苯基-3-甲基-5-氯吡唑-4-基)-1,3,4-噻二唑-2-基]-硫脲

1-苯基-3-甲基-5-氯吡唑-4-甲酸与氨基硫脲在三氯氧磷中反应得到2-氨基-5-(1-苯基-3-甲基-5-氯吡唑-4-基)-1,3,4-噻二唑(1), 然后分别采用超声辐射法和常规加热法与(未)取代苯甲酰基异硫氰酸酯(2)反应合成了一系列未见报到的1-[(未)取代苯酰基-3-[5-(1-苯基-3-甲基-5-氯吡唑-4-基)-1,3,4-噻二唑-2-基]-硫脲(3a～3j). 化合物的结构经元素分析, IR, ¹H NMR确证.     

肟醚噻二唑硫醚化合物的合成及其抗肿瘤活性

将2-巯基-5-取代基-1,3,4-噻二唑经与β-氯苯丙酮取代、盐酸羟胺肟化和氯甲基噁二唑醚化,合成了6种3-(5-取代基-1,3,4-噻二唑-2-硫代基)-1-苯基丙酮-O-(5-苯基-1,3,4-噁二唑-2-甲基)肟醚化合物(4a~4f),用1H NMR、IR、MS和元素分析表征了其结构。 用MTT法测试了6种目标化合物对人黑色素瘤细胞株B16、人白血病细胞株HL60和人肝癌细胞株SMMC-7721的体外细胞毒活性。 测试结果表明,部分化合物对3种癌细胞具有潜在的体外生长抑制活性。     

Design and synthesis of novel quinoline derivatives bearing oxadiazole,isoxazoline, triazolothiadiazole,triazolothiadiazine, and piperazine moieties

A new series of 2,3-disubstituted quinoline derivatives were synthesized from 2-chloroquinoline-3-carbaldehyde. In the reaction sequence, acetanilide was cyclized to give 2-chloroquinoline-3-carbaldehyde 1 , which was transformed to 2-(4-phenylpiperazin-1-yl)quinolin-3-carbaldehyde 2 by reaction with 4-phenylpiperazine in DMF-containing anhydrous K₂CO₃; then, compound 2 was oxidized by iodine in methanol, and methyl 2-(4-phenylpiperazin-1-yl)quinoline-3-carboxylate 3 was synthesized. The key intermediate 4 , 4-amino-5-[2-(4-phenylpiperazin-1-yl)quinolin-3-yl]-4H-1,2,4-triazole-3-thiol, was prepared using the ester 3 by a series of step. Reaction of 5 with various aromatic carboxylic acids or phenacyl bromides yielded 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles 5a-c and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines 6a-c , respectively. Moreover, compound 2 condensed with o-phenylenediamine to give 2-[2-(4-phenylpiperazin-1-yl)quinolin-3-yl]-1H-benzimidazole 7 . Interaction of 7 and 2-chloromethyl-5-aryl-1,3,4-oxadiazoles in the presence of K₂CO₃ led to the title compounds 8a-c . Furthermore, 4,5-dihydroisoxazoline derivatives 9a-c were obtained by the reaction of readily accessible starting materials including 2-(4-phenylpiperazin-1-yl)quinolin-3-carbaldehyde 2 , 1-phenyl-2-(triphenylphosphoranylidene)ethanone and hydroximoyl chlorides under mild conditions in the presence of Et₃N. The hydrazone intermediates 10a-c were obtained by the condensation of 2 with aroylhydrazides in ethanol, then, refluxing in acetic anhydride yielded 3-acetyl-5-aryl-2-[2-(4-phenylpiperazin-1-yl)quinolin-3-yl]-2,3-dihydro-1,3,4-oxadiazoles 11a-c . Structures of these compounds were established by their elemental analysis, IR, ¹H NMR, and mass spectral data.     

Synthesis of new 1,2,4-triazole[3,4-b][1,3,4]thiadiazoles bearing pyrazole as potent antimicrobial agents

A new series of 6-(aryl/heteryl)-3-(5-methyl-1-phenyl-1H-4-pyrazolyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles (7a-j) has been synthesized by the reaction of 4-amino-5-(5-methyl-1-phenyl-1H-4-pyrazolyl)-4H-1,2,4-triazol-3-yl-hydrosulfide (6) with POCl(3) and the corresponding aryl/heteryl carboxylic acid, in ethanol at reflux temperature for 12 h. All the synthesized compounds were tested for in vitro activities against certain strains of bacteria such as Staphylococcus aureus, Bacillus subtilis, Escherichia coli and fungi such as Aspergillus niger, Aspergillus nodulans, Alternaria alternate. Compounds having 4-chlorophenyl (7d), 4-aminophenyl (7f), 4-nitrophenyl (7h) and 3-pyridyl (7i) substituents at 6-position of thiadiazole ring, showed marked inhibition of bacterial and fungal growth nearly equal to the standards. The other new compounds also showed appreciable activity against the test bacteria and fungi.     

Synthesis and in-vitro antioxidant activities of some coumarin derivatives containing 1,2,3-triazole ring

A new green protocol was developed for the S-alkylation of 2-mercapto-1,3,4-oxadiazole by the reaction of 5-substituted-2-mercapto-1,3,4-oxadiazole with propargyl bromide in sodium bicarbonate in water. The newly synthesized 5-[(substitutedphenoxy)methyl]-2-[(prop-2-yn-1-yl)sulfanyl]-1,3,4-oxadiazole when reacted with azidomethyl coumarins underwent regioselective reaction yielding 4-(((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethyl)-1H-1,2,3-triazol-1-yl)methyl)-6-methyl)-2H-chromene-2-one or 1-((4-((5-((substitutedphenoxy)methyl)-1,3,4-oxadiazol-2-yl)sulfanylmethy)-1H-1,2,3-triazol-1-yl-)methyl)-3H-benzo[f]chromene-3-one. Structures of the newly synthesized compounds were confirmed by spectral and analytical data. The compounds were screened for their in-vitro antioxidant property.     

Synthesis and in vitro antibacterial activity of new oxoethylthio-1,3,4-oxadiazole derivatives

In the present investigation, a series of 2(4-pyridyl)-5[(aryl/heteroarylamino)-1-oxoethyl]thio-1,3,4-oxadiazole were synthesized using isonicotinohydrazide and substituted aryl/heteroaryl amines using pyridine as solvent. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compounds 2(4-pyridyl)-5((2-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5e), 2(4-pyridyl)-5((4-nitrophenylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5g) and 2(4-pyridyl)-5((2-pyrrolylamino)-1-oxoethyl)thio-1,3,4-oxadiazole (5k) produced highest efficacy and exhibited >90% inhibition at a concentration of 0.0077, 0.0052 and 0.0089 μM, respectively. All the new compounds were pharmacologically evaluated for their in vitro Antimicrobial activity.     

抗肿瘤氟喹诺酮C3等排衍生物——噁二唑曼尼希碱衍生物的合成和抗肿瘤活性

用噁二唑硫酮杂环作为培氟沙星(1)的C3羧基电子等排体,得中间体C3噁二唑硫酮4(5),再将其与仲胺或取代苯胺及甲醛通过氨甲基化反应形成系列氟喹诺酮C3噁二唑硫酮曼尼希碱(6a~6j)目标化合物。 用元素分析、1H NMR和MS测试技术确证了目标化合物的组成和结构。 采用MTT法评价了目标化合物对体外培养人肝癌Hep-3B细胞生长的抑制活性。 结果表明,10种目标化合物活性均显著高于对照化合物1的活性,并且脂肪胺曼尼希碱的活性高于芳香胺曼尼希碱的活性。     

含吡啶环的1,3,4-噁二唑衍生物的合成及生物活性研究

依据生物电子等排原理,在分子中同时引入吡啶环和1,3,4-噁二唑杂环合成了5-(3-吡啶基或4-吡啶基)-1,3,4-噁二唑2-硫乙酸胺类化合物,用¹HNMR,IR,质谱和元素分析对其结构进行了表征.离体试验表明,化合物B1-5小麦赤霉病菌和苹果轮纹病菌的抑制率分别为30%和42%,化合物B1-6对苹果轮纹病菌的抑制率为38%.除草活性实验结果表明,化合物B1-6对油菜和稗草具有较高的抑制作用.     

微波促进下3-(2-苯并呋喃基)-4-氨基-5-巯基-1,2,4-三唑

微波辐射条件下, 首先由2-苯并呋喃甲酰肼依次与二硫化碳和水合肼反应合成3-(2-苯并呋喃基)-4-氨基-5-巯基- 1,2,4-三唑, 进一步在微波辐射条件下由4-氨基-5-巯基-1,2,4-三唑分别与芳甲酸/芳氧基乙酸、α-溴代苯乙酮及芳醛反应以较高产率制得了相应的1,2,4-三唑并[3,4-b]-1,3,4-噻二唑、1,2,4-三唑并[3,4-b]-1,3,4-噻二嗪及4-芳亚甲基亚胺基-5-巯基-1,2,4-三唑. 产物结构经IR, ¹H NMR, MS及元素分析进行了表征.     

Synthesis of 6-aryl substituted 3-(5''''-phenyl-2H-tetrazole-2''''-methylene)-S-triazolo[3,4-b]-1,3,4-thiadiazoles

In this paper , 10 novel 6-aryl-3-(5'-phenyl-2H-tetrazole-2'-methylene)-S-triazolo[3, 4-b]-1,3,4-thiadiazoles have been synthesized by the condensation of 3-(5'-phenyl-2H-tetrazole-2'-methylene)-4-amino-5-mercapto-1,2,4-triazole with various aromatic carboxylic acids in the presence of phosphorus oxychloride. The structure of these compounds was determined by elemental analysis , UV, IR, 1H NMR and MS. Their spectral properties were also discussed.     

3-杂环硫亚甲基头孢菌素衍生物的半合成及抗菌活性研究

通过取代噁二唑硫酮、噻二唑硫酮及三唑硫酮分别和头孢菌素母体7-ACA反应,制得14种7-氨基-3-杂环硫亚甲基头孢菌素新母体2a-2n,用1-芳基-5-甲基-1H-1,2,3-三唑-4-甲酰氯与头孢菌素新母体缩合,制得2种新的7β-(1-芳基-5-甲基-1H-1,2,3-三唑-4-甲酰胺基)-3-(2-取代1,3,4-bI二唑-5-硫亚甲基)头孢菌素4c,4d.新化合物结构经元素分析、IR、¹HNMR及FAB-MS确认.初步体外抗菌结果表明,新母体化合物2对革兰氏阳性菌有抑制活性且在相同浓度下比7-ACA强20倍,而头孢菌素4c,4d对革兰氏阳性和阴性菌都有显著抑制活性.